Combinatorial treatment of idiopathic pulmonary fibrosis using nanoparticles with prostaglandin E and siRNA(s)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Combinatorial treatment of idiopathic pulmonary fibrosis using nanoparticles with prostaglandin E and siRNA(s)

Published:2017-08 Issue:6 Volume:13 Page:1983-1992
ISSN:1549-9634
Container-title:Nanomedicine: Nanotechnology, Biology and Medicine
language:en
Short-container-title:Nanomedicine: Nanotechnology, Biology and Medicine

Author:

Garbuzenko Olga. B.,Ivanova Vera,Kholodovych Vladislav,Reimer David. C.,Reuhl Kenneth R.,Yurkow Edvard,Adler Derek,Minko Tamara

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Materials Science,Biomedical Engineering,Molecular Medicine,Medicine (miscellaneous),Bioengineering

Reference28 articles.

1. Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review;Hutchinson;Eur Respir J,2015

2. Recent evidence for pharmacological treatment of idiopathic pulmonary fibrosis;Covvey;Ann Pharmacother,2014

3. New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis: a potential role for stem cells in the lung parenchyma and implications for therapy;Gharaee-Kermani;Pharm Res,2007

4. Fibrosis of the lung and other tissues: new concepts in pathogenesis and treatment;Sime;Clin Immunol,2001

5. Inhalation treatment of pulmonary fibrosis by liposomal prostaglandin E2;Ivanova;Eur J Pharm Biopharm,2013

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipid nanoparticles for pulmonary fibrosis: A comprehensive review;Pulmonary Pharmacology & Therapeutics;2024-12

2. Research Progress on Liposome Pulmonary Delivery of Mycobacterium tuberculosis Nucleic Acid Vaccine and Its Mechanism of Action;Journal of Aerosol Medicine and Pulmonary Drug Delivery;2024-04-26

3. Revolutionizing the Treatment of Idiopathic Pulmonary Fibrosis: From Conventional Therapies to Advanced Drug Delivery Systems;AAPS PharmSciTech;2024-04-08

4. Novel inhalation therapy in pulmonary fibrosis: principles, applications and prospects;Journal of Nanobiotechnology;2024-03-29

5. Emerging delivery approaches for targeted pulmonary fibrosis treatment;Advanced Drug Delivery Reviews;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3